Age-related muscle degeneration, clinically known as sarcopenia, is the progressive loss of muscle mass, strength, and physical function that comes with ageing. The single most important thing to know: you can slow it, and in many cases partially reverse it, with progressive resistance training and adequate dietary protein. If you suspect it is already affecting you, booking a GP appointment and asking about a handgrip strength test or SARC-F screening questionnaire is the right first move. Diagnostic tools like the DXA scan and gait speed test give clinicians an objective picture of where you stand, and the European Working Group on Sarcopenia in Older People (EWGSOP) has established the consensus criteria most Australian specialists use to grade severity.
Key takeaways
Sarcopenia is a progressive, partially reversible condition: the earlier you act with resistance training and adequate protein, the more muscle function you can protect and recover.
Point
Details
Definition and onset
Sarcopenia is progressive loss of muscle mass, strength, and function; decline can begin around age 30 and accelerates after 50.
Primary treatment
Progressive resistance training (2–3 sessions per week) combined with 1.2–1.6 g protein per kilogram of body weight daily is the first-line approach.
Diagnosis pathway
Ask your GP about SARC-F screening, handgrip strength testing, gait speed assessment, and DXA scan for muscle quantity.
When to seek help
See your GP promptly if you have had two or more falls in the past year, rapid functional decline, or significant unintentional weight loss.
Lifespan Dynamics adjunct
Red and NIR light therapy devices from Lifespan Dynamics support post-exercise recovery and inflammation reduction as part of a clinician-supervised plan.
What is age-related muscle degeneration, and how common is it?
Sarcopenia is not simply “getting weaker with age.” Clinically, it involves three distinct but related problems: loss of muscle mass (the actual tissue), reduced muscle strength (how much force you can produce), and declining physical performance (how well you move through daily life). You can have two of these without the third, which is why diagnosis requires more than one test.
Think of it this way: muscle mass is the engine size, strength is the horsepower it delivers, and physical performance is how the car handles on the road. Ageing can quietly shrink the engine before the driver notices anything wrong.
Adults who do no regular strength training may lose muscle over time, often replacing it with fat, so body weight stays stable while composition quietly shifts.
Sarcopenia affects a meaningful proportion of older Australians, with prevalence rising steeply in those aged 70 and above.
The condition frequently coexists with bone loss, a combination researchers call osteosarcopenia. Bone and muscle tissue are metabolically linked, so when one deteriorates, the other often follows. This is why a bone density check is worth discussing alongside any sarcopenia assessment.
One detail many people miss: because body weight can stay the same while muscle is replaced by fat, the bathroom scale is a poor early-warning tool. Monitoring strength and function is far more sensitive than tracking kilograms.
How does ageing actually cause muscle loss?
The biology behind sarcopenia involves several overlapping mechanisms, not a single switch being flipped. Understanding them helps explain why the treatment approach has to be multi-pronged.
Anabolic resistance is perhaps the most clinically important driver. In younger muscles, a moderate protein meal and a bout of exercise reliably trigger muscle protein synthesis, the repair-and-build process. In older muscle, that signal is turned down: you need a larger protein dose, better timing, and a stronger exercise stimulus to get the same response. It is not that the machinery is broken; it is that the sensitivity dial has been wound back.
Other key mechanisms:
Muscle fibre atrophy and fibre loss. Type II (fast-twitch) fibres, the ones responsible for power and speed, shrink and disappear faster than Type I fibres. This is why older adults often lose explosive strength before they lose endurance.
Mitochondrial dysfunction. Mitochondria are the energy factories inside muscle cells. With age, they become less efficient and more prone to damage, reducing the muscle’s capacity to sustain effort and recover.
Neuromuscular junction deterioration. The connection between nerve and muscle fibre degrades. Motor neurons are lost, and the reinnervation that replaces them is imperfect. This is why strength and power can decline faster than measurable mass loss: the wiring is failing before the engine visibly shrinks.
Chronic low-grade inflammation. Elevated inflammatory markers, sometimes called “inflammageing,” interfere with muscle repair signals and accelerate protein breakdown.
Hormonal changes. Declining testosterone, oestrogen, growth hormone, and IGF-1 reduce the anabolic environment muscles depend on.
Satellite cell exhaustion. Satellite cells are the stem cells that repair muscle fibres after damage. Their number and responsiveness decline with age, slowing recovery from exercise and injury.
Disuse. Physical inactivity is often a larger contributor to clinically meaningful muscle loss than chronological ageing alone. Inactivity amplifies every biological mechanism above, creating a compounding effect.
Photobiomodulation (red and near-infrared light) is increasingly used as an adjunct to support cellular recovery, partly because it targets mitochondrial function and inflammation at the cellular level. More on that in the adjunct therapies section below.
Who is at higher risk of sarcopenia?
Age is the primary driver, but it does not act alone. Several factors stack on top of each other, and knowing which ones apply to you helps determine whether earlier screening makes sense.
Age and sex. Risk climbs steadily after midlife and accelerates in the late 60s and 70s. Men tend to have more absolute muscle mass to begin with, but women often experience a sharper relative decline around menopause due to oestrogen loss. By the mid-70s, the gap narrows considerably.
Lifestyle factors that raise risk significantly:
Prolonged physical inactivity or a sedentary job with no compensatory exercise
Consistently low protein intake, particularly common in older adults who eat smaller meals or follow restrictive diets
Rapid unintentional weight loss, which almost always includes substantial muscle loss alongside fat
Chronic diseases including heart failure, chronic obstructive pulmonary disease, type 2 diabetes, and kidney disease all accelerate muscle catabolism
Malabsorption conditions (coeliac disease, inflammatory bowel disease) that impair protein and micronutrient uptake
Medications including corticosteroids, some statins at high doses, and certain chemotherapy agents
Hormonal deficiencies (low testosterone, hypothyroidism) that reduce the anabolic environment
If you have two or more of these risk factors, it is worth raising sarcopenia screening with your GP before you notice obvious symptoms. The earlier the intervention, the more muscle you have to work with.
What are the signs and symptoms of sarcopenia?
Sarcopenia tends to creep up rather than announce itself. The earliest signs are functional: tasks that used to feel easy start requiring noticeably more effort. By the time someone notices significant weakness, meaningful muscle has already been lost.
Watch for these symptoms:
Difficulty rising from a chair without using your arms, or needing to rock forward to get up
Slowing walking pace, particularly noticeable when crossing a road or keeping up with others
Struggling with stairs, especially descending, which requires eccentric muscle control
Frequent trips, stumbles, or falls, even on flat ground
Reduced grip strength: jars are harder to open, carrying shopping bags feels heavier than it used to
Fatigue with daily tasks that previously felt effortless, such as carrying groceries or gardening
Unintentional weight loss alongside visible loss of muscle bulk in the thighs, upper arms, or calves
Red flags that need prompt assessment rather than a routine appointment:
Rapid functional decline over weeks rather than months
Recurrent falls (two or more in the past year)
Significant unintentional weight loss (more than 5% of body weight in six months)
Sudden inability to perform a task that was manageable recently
A useful self-check: the SARC-F questionnaire asks five simple questions about strength, walking, rising from a chair, climbing stairs, and falls. A score of four or more suggests sarcopenia is likely and warrants formal assessment.
How do clinicians screen and diagnose sarcopenia?
Diagnosis is not a single test. Current consensus, including the EWGSOP2 framework used widely in Australian clinical practice, combines strength, quantity, and performance measures to grade severity. Here is how each tool works and what it tells you.
Test
What it measures
Typical cut-off (EWGSOP2)
What a low result means
SARC-F questionnaire
Self-reported function and falls
Score ≥ 4
Likely sarcopenia; proceed to objective tests
Handgrip strength (dynamometer)
Muscle strength
< 30 kg (men), < 20 kg (women)
Probable sarcopenia; assess muscle quantity
4-metre gait speed test
Physical performance
≤ 1 m/s
Severe sarcopenia when combined with low strength/mass
DXA scan
Muscle mass (appendicular lean mass)
Varies by height and population
Confirms low muscle quantity; reference standard
Bioelectrical impedance (BIA)
Muscle mass estimate
Varies by device and equation
Useful screening tool; less precise than DXA
A few practical notes on these tests:
SARC-F is a five-question screening tool your GP can administer in under two minutes. It is not diagnostic on its own, but a score of four or above is a reliable prompt to investigate further.
Handgrip strength is measured with a handheld dynamometer. The cut-offs above are EWGSOP2 consensus values; some Australian guidelines use slightly different thresholds depending on the population studied. A single low reading is meaningful, but clinicians usually take the best of three attempts.
Gait speed over four metres is deceptively simple and highly predictive. Slow gait speed correlates with falls risk, hospitalisation, and mortality in older adults, independent of muscle mass alone.
DXA (dual-energy X-ray absorptiometry) is the reference standard for measuring muscle quantity. It is the same machine used for bone density scans, so both can often be assessed in one appointment. Some specialist clinics and hospitals offer this; your GP can refer you.
BIA (bioelectrical impedance analysis) is more accessible and available in many GP clinics and dietitian practices, but results vary by hydration status and the equation used. It is a reasonable screening tool when DXA is not available.
The clinical pathway in Australia typically runs: GP assessment with SARC-F and handgrip test → blood tests (vitamin D, thyroid, inflammatory markers, full blood count) → referral for DXA or allied health assessment → physiotherapist and/or accredited exercise physiologist for a tailored programme.
What is the evidence-based treatment for sarcopenia?
A clinically grounded resistance training programme for sarcopenia typically includes:
Frequency: 2–3 sessions per week, with at least one rest day between sessions.
Intensity: Moderate to high, targeting 70–85% of one-repetition maximum (or a perceived effort of 6–8 out of 10). Lighter loads with higher repetitions can work, but higher intensities produce faster strength gains.
Sets and reps: 2–4 sets of 8–12 repetitions per exercise, progressing as strength improves.
Progression: Increase load by roughly 5–10% when you can complete all sets and reps with good form and the effort feels manageable.
Exercise selection: Prioritise compound movements: squats or sit-to-stand, step-ups, leg press, rows, and overhead press. These recruit the largest muscle groups and have the greatest functional carryover.
Nutrition targets
Older adults with sarcopenia generally need more protein than standard dietary guidelines suggest, because of anabolic resistance. A commonly cited target in clinical reviews is 1.2–1.6 g of protein per kilogram of body weight per day, distributed across meals rather than concentrated in one sitting. Spreading protein intake across three or four meals appears to stimulate muscle protein synthesis more effectively than eating most of it at dinner.
Where whole-food protein intake is insufficient, whey protein supplementation has the strongest evidence base among supplements, partly because of its high leucine content, which is a key trigger for muscle protein synthesis.
Vitamin D deserves a specific mention. Deficiency is common in older Australians, particularly those with limited sun exposure, and low vitamin D is associated with reduced muscle function. A blood test through your GP will confirm your level; supplementation is straightforward if deficient.
Multidisciplinary care
The most effective outcomes come from a team approach:
GP: coordinates testing, rules out secondary causes, manages medications
Physiotherapist or accredited exercise physiologist: designs and supervises the resistance programme
Dietitian: personalises protein and micronutrient targets
Geriatrician or specialist: involved when sarcopenia is severe, rapidly progressing, or complicated by multiple comorbidities
Evidence comparison: treatment approaches
Approach
Evidence level
Primary role
Notes
Progressive resistance training
Strong (multiple RCTs and meta-analyses)
First-line treatment
Improves strength, mass, and function
Protein and nutritional optimisation
Strong
Essential adjunct to exercise
Higher targets needed due to anabolic resistance
Vitamin D supplementation (if deficient)
Moderate
Corrects deficiency-related weakness
Test before supplementing
Photobiomodulation (red/NIR light)
Emerging (mechanistic and early clinical data)
Adjunct to exercise and nutrition
Supports recovery and inflammation reduction
Pharmacological agents
Limited / investigational
Not yet standard care
Under active research
Timeline for improvement: Measurable strength gains often appear within 6–8 weeks of consistent resistance training. Meaningful functional improvements, such as faster gait speed or easier stair climbing, typically emerge over 3–6 months. Muscle mass recovery is slower and more variable, particularly in those with long-standing sarcopenia.
A safe starter resistance programme for older adults
You do not need a gym membership or complex equipment to begin. The following plan is designed for someone starting from a low base; if you have significant mobility limitations or cardiovascular concerns, discuss it with your GP or physiotherapist first.
Weekly structure: 2–3 resistance sessions, plus daily walking and one balance session.
Session exercises (choose a flat surface, have a chair nearby for support):
Sit-to-stand (squat equivalent): Rise from a chair without using your hands, lower slowly. Start with 2 sets of 8; progress to 3 sets of 12, then add a weighted vest or hold light dumbbells.
Step-ups: Use a low, stable step. Alternate legs. 2 sets of 8 per leg.
Resistance band rows: Anchor a band at chest height, pull elbows back. 2 sets of 10.
Heel raises: Stand behind a chair for balance, rise onto toes slowly, lower slowly. 2 sets of 12.
Wall push-ups or bench push-ups: Adjust the angle to suit your current strength. 2 sets of 8–10.
Balance session (10–15 minutes, any day): Single-leg stance (hold a bench or wall), tandem walking (heel-to-toe along a line), and gentle side-stepping.
Progression rules:
When all sets feel manageable (effort below 6 out of 10), add one repetition per set.
When you reach the top of the rep range consistently, increase resistance (heavier band, add weight, increase step height).
Add a third set before adding a fourth exercise.
Safety checkpoints:
Warm up with 5 minutes of gentle walking or marching on the spot.
Breathe out on the effort phase; never hold your breath.
Muscle fatigue and mild soreness the next day are normal. Sharp joint pain, chest tightness, dizziness, or unusual shortness of breath are not: stop and seek medical advice.
Pro Tip:If rising from a chair is currently difficult, start with a higher chair or use a cushion to raise the seat height. As strength improves, lower the seat progressively. This is a safe, measurable way to track functional progress without any equipment.
Can red and near-infrared light therapy support muscle recovery?
Photobiomodulation (PBM), the clinical term for red and near-infrared (NIR) light therapy, is an emerging adjunct in sarcopenia management. It does not replace resistance training or nutrition; the evidence for those is far stronger. What the mechanistic and early clinical data suggest is that PBM can support the conditions that make training more effective.
The biological rationale is straightforward. Red and NIR wavelengths penetrate tissue and are absorbed by cytochrome c oxidase, an enzyme in the mitochondrial respiratory chain. This appears to boost cellular ATP production and reduce oxidative stress, two processes that are compromised in ageing muscle. Separately, PBM has demonstrated anti-inflammatory effects in multiple mechanistic studies, which matters because chronic low-grade inflammation is one of the key drivers of sarcopenia.
Clinical use is increasing, particularly as a post-exercise recovery tool. The rationale: if inflammation and cellular energy deficits slow recovery between training sessions, reducing them may allow older adults to train more consistently and with less downtime. Some practitioners also use it to support muscle repair following injury or hospitalisation.
How it fits into a sarcopenia plan:
Use as an adjunct to, not a replacement for, resistance training and protein targets.
Post-workout light therapy routines typically involve 10–20 minutes of device exposure to the major muscle groups worked, within an hour of training.
Discuss with your GP or physiotherapist before starting, particularly if you have photosensitive conditions or are taking photosensitising medications.
Look for devices with peer-reviewed wavelength parameters (typically 630–850 nm for red and NIR) and adequate irradiance. Clinical-grade devices offer more consistent dosing than consumer-grade alternatives.
Lifespan Dynamics offers both clinical and at-home red and NIR light therapy devices developed in collaboration with clinical researchers, designed to deliver consistent, evidence-aligned parameters for muscle recovery and inflammation support.
Pro Tip:Combine a 10–15 minute PBM session with your post-workout protein meal. Both target the recovery window after resistance training, and pairing them is more practical than treating them as separate routines.
How to reduce your risk of sarcopenia across midlife and later life
Prevention is substantially easier than reversal. The habits that protect muscle mass are the same ones that protect cardiovascular health, bone density, and cognitive function, so the investment compounds across multiple systems.
Core lifetime actions:
Start resistance training before you need it. Midlife is not too early; it is the ideal time to build a muscle reserve that buffers the inevitable age-related decline. Small, consistent habits matter more than sporadic high-effort periods.
Meet your protein target daily. Aim for at least 1.2 g per kilogram of body weight, distributed across meals. Prioritise high-quality sources: eggs, lean meat, fish, dairy, legumes, and tofu.
Avoid prolonged inactivity. Even a week of bed rest or illness-related inactivity causes measurable muscle loss in older adults. Gentle movement during recovery, where safe, is protective.
Maintain a healthy weight. Both obesity and underweight status increase sarcopenia risk. Rapid weight loss, even when intentional, carries significant muscle loss unless protein intake and resistance training are maintained throughout. If you are taking weight-loss medications, protecting muscle mass during treatment requires specific nutritional attention.
Check and maintain vitamin D status. A simple blood test through your GP confirms your level. Supplementation is inexpensive and effective when deficient.
Manage chronic conditions actively. Conditions like type 2 diabetes, heart failure, and inflammatory diseases accelerate muscle catabolism. Good disease management slows that process.
Include balance training. Tai chi, yoga, and single-leg exercises reduce falls risk independently of muscle mass, and falls are one of the fastest routes to the bed rest that accelerates sarcopenia.
For Australians looking for structured community support, Get Active Victoria offers practical movement and strength programmes for older adults. Medicare-funded allied health plans (through a GP Management Plan) can also provide subsidised access to physiotherapy and exercise physiology for those with chronic conditions.
When should you see a GP about muscle loss?
See your GP promptly if you notice:
Two or more falls in the past 12 months
Rapid functional decline over weeks (tasks becoming difficult that were manageable recently)
Significant unintentional weight loss, more than 5% of body weight over six months
Severe or worsening weakness that is affecting your independence
Any combination of slow walking, difficulty rising from a chair, and reduced grip strength
At the appointment, your GP will likely:
Administer or ask you to complete the SARC-F questionnaire
Measure handgrip strength with a dynamometer
Assess gait speed (often informally, by observing how you walk into the room, or formally with a timed walk)
Order blood tests: vitamin D, thyroid function, full blood count, inflammatory markers (CRP, ESR), and kidney and liver function
Review your medications for any that accelerate muscle loss
Refer for DXA if muscle quantity assessment is needed, or to a physiotherapist, accredited exercise physiologist, or dietitian for a structured programme
To get the most from the appointment, bring a list of your current medications, note any specific tasks that have become harder and roughly when you first noticed the change, and mention any recent falls or near-misses. Healthdirect Australia has a useful overview of what to expect and how to prepare.
Can sarcopenia be reversed, and what should you realistically expect?
Partial reversal is genuinely possible, particularly when intervention begins before the condition is severe. The word “partial” matters here: the neuromuscular changes that accumulate over decades, including motor neuron loss and imperfect reinnervation, cannot be fully undone. But the functional gains from a well-structured programme can be substantial enough to restore independence and meaningfully reduce falls risk.
Realistic timelines:
Strength: Often the fastest to respond. Measurable gains within 6–8 weeks of consistent resistance training are well documented, partly because early gains reflect neural adaptation (the nervous system learning to recruit existing muscle fibres more efficiently) rather than new tissue growth.
Physical function: Gait speed, stair-climbing ability, and chair-rise time typically improve over 3–6 months of consistent training and adequate nutrition.
Muscle mass: The slowest to recover. Meaningful mass gains require months to years of consistent effort, and older adults with long-standing severe sarcopenia may see limited mass recovery even with excellent adherence.
Factors that influence how much recovery is achievable:
Age and baseline health: Younger older adults (60s and early 70s) with good general health tend to respond faster and more fully.
Adherence: Consistency matters more than intensity. Three moderate sessions per week, sustained over months, outperforms sporadic high-effort bursts.
Comorbidities: Chronic inflammation, diabetes, and cardiac conditions slow the response and may require specialist input to manage alongside the exercise programme.
Degree of neurodegeneration: Significant motor neuron loss limits how much mass and strength can be recovered, regardless of training quality.
The encouraging reality is that resistance training and targeted nutrition produce meaningful improvements at virtually any age. Studies in adults in their 80s and 90s show strength and function gains from structured programmes. Starting later is not ideal, but it is never too late to benefit.
An honest perspective on what actually moves the needle
The clinical evidence on sarcopenia is clearer than most people realise, and the gap between what the research supports and what older adults are actually doing is wide. Resistance training and protein intake are not optional extras for ageing well; they are the primary intervention, and the data behind them is as strong as the evidence for many medications prescribed for age-related conditions.
What tends to get underestimated is how quickly muscle responds to the right stimulus, even in older adults. The early strength gains from resistance training, driven largely by neural adaptation, can appear within weeks and feel genuinely motivating. That momentum matters, because adherence is the variable that determines long-term outcomes more than any specific programme design.
Where adjunct therapies like photobiomodulation fit is as a recovery support, not a shortcut. The mitochondrial and anti-inflammatory mechanisms are real and increasingly well-documented. Used alongside a consistent resistance programme and adequate protein, they can help older adults recover between sessions more effectively, which means training more consistently. That is the mechanism through which they contribute, not by replacing the hard work of exercise.
The practical advice: start with your GP, get a baseline assessment, and build the exercise and nutrition habits first. If you want to explore light therapy as a recovery adjunct, discuss it with your clinician and look for devices with peer-reviewed parameters. Lifespan Dynamics devices are developed with clinical researchers and designed for exactly this kind of supervised, evidence-aligned use.
Lifespan Dynamics light therapy devices: a clinician-aligned adjunct for muscle recovery
If you are building a sarcopenia management plan around resistance training and nutrition, and you want to support your recovery between sessions, Lifespan Dynamics offers red and near-infrared light therapy devices designed for both clinical and home use.
Developed in collaboration with internationally recognised researchers, including Professor Sungkyoo Lim, these devices are built to deliver consistent, peer-reviewed wavelength parameters for muscle recovery and inflammation reduction. They are used by physiotherapists, exercise physiologists, and individuals managing chronic conditions at home. The positioning is clear: these are adjuncts to exercise and nutrition, not replacements. Used as part of a clinician-supervised plan, they support the cellular recovery processes that make consistent training possible.
To explore the range of at-home and clinical devices, or to discuss which option suits your situation, visit the Lifespan Dynamics website. Always discuss new therapies with your GP or allied health provider before starting.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Can you reverse muscle degeneration?
Partial reversal is possible, particularly with early intervention. Progressive resistance training and adequate protein intake can restore meaningful strength and function, though full recovery of lost muscle mass, especially after years of decline, is unlikely. Starting earlier produces better outcomes.
Can a 70-year-old regain muscle mass?
Yes. Studies in adults in their 70s, 80s, and beyond consistently show strength and functional gains from structured resistance training. Mass recovery is slower than strength recovery, but measurable improvements in both are achievable with consistent effort and sufficient protein intake.
What are the main symptoms of sarcopenia?
The four most common functional signs are difficulty rising from a chair without using your arms, a noticeably slower walking pace, reduced grip strength (trouble opening jars or carrying bags), and an increased tendency to trip or fall. Fatigue with tasks that previously felt easy is also a reliable early indicator.
How do you know if you have muscle degeneration?
The SARC-F questionnaire is a simple five-question self-screen; a score of four or more suggests sarcopenia is likely. Objective confirmation comes from a handgrip strength test, a four-metre gait speed assessment, and muscle mass measurement via DXA scan or bioelectrical impedance, all available through a GP referral in Australia.
Age-related muscle degeneration: what it is and what you can do
Age-related muscle degeneration, clinically known as sarcopenia, is the progressive loss of muscle mass, strength, and physical function that comes with ageing. The single most important thing to know: you can slow it, and in many cases partially reverse it, with progressive resistance training and adequate dietary protein. If you suspect it is already affecting you, booking a GP appointment and asking about a handgrip strength test or SARC-F screening questionnaire is the right first move. Diagnostic tools like the DXA scan and gait speed test give clinicians an objective picture of where you stand, and the European Working Group on Sarcopenia in Older People (EWGSOP) has established the consensus criteria most Australian specialists use to grade severity.
Key takeaways
Sarcopenia is a progressive, partially reversible condition: the earlier you act with resistance training and adequate protein, the more muscle function you can protect and recover.
Table of Contents
What is age-related muscle degeneration, and how common is it?
Sarcopenia is not simply “getting weaker with age.” Clinically, it involves three distinct but related problems: loss of muscle mass (the actual tissue), reduced muscle strength (how much force you can produce), and declining physical performance (how well you move through daily life). You can have two of these without the third, which is why diagnosis requires more than one test.
Think of it this way: muscle mass is the engine size, strength is the horsepower it delivers, and physical performance is how the car handles on the road. Ageing can quietly shrink the engine before the driver notices anything wrong.
Key facts about prevalence and onset:
One detail many people miss: because body weight can stay the same while muscle is replaced by fat, the bathroom scale is a poor early-warning tool. Monitoring strength and function is far more sensitive than tracking kilograms.
How does ageing actually cause muscle loss?
The biology behind sarcopenia involves several overlapping mechanisms, not a single switch being flipped. Understanding them helps explain why the treatment approach has to be multi-pronged.
Anabolic resistance is perhaps the most clinically important driver. In younger muscles, a moderate protein meal and a bout of exercise reliably trigger muscle protein synthesis, the repair-and-build process. In older muscle, that signal is turned down: you need a larger protein dose, better timing, and a stronger exercise stimulus to get the same response. It is not that the machinery is broken; it is that the sensitivity dial has been wound back.
Other key mechanisms:
Photobiomodulation (red and near-infrared light) is increasingly used as an adjunct to support cellular recovery, partly because it targets mitochondrial function and inflammation at the cellular level. More on that in the adjunct therapies section below.
Who is at higher risk of sarcopenia?
Age is the primary driver, but it does not act alone. Several factors stack on top of each other, and knowing which ones apply to you helps determine whether earlier screening makes sense.
Age and sex. Risk climbs steadily after midlife and accelerates in the late 60s and 70s. Men tend to have more absolute muscle mass to begin with, but women often experience a sharper relative decline around menopause due to oestrogen loss. By the mid-70s, the gap narrows considerably.
Lifestyle factors that raise risk significantly:
Medical contributors:
If you have two or more of these risk factors, it is worth raising sarcopenia screening with your GP before you notice obvious symptoms. The earlier the intervention, the more muscle you have to work with.
What are the signs and symptoms of sarcopenia?
Sarcopenia tends to creep up rather than announce itself. The earliest signs are functional: tasks that used to feel easy start requiring noticeably more effort. By the time someone notices significant weakness, meaningful muscle has already been lost.
Watch for these symptoms:
Red flags that need prompt assessment rather than a routine appointment:
A useful self-check: the SARC-F questionnaire asks five simple questions about strength, walking, rising from a chair, climbing stairs, and falls. A score of four or more suggests sarcopenia is likely and warrants formal assessment.
How do clinicians screen and diagnose sarcopenia?
Diagnosis is not a single test. Current consensus, including the EWGSOP2 framework used widely in Australian clinical practice, combines strength, quantity, and performance measures to grade severity. Here is how each tool works and what it tells you.
A few practical notes on these tests:
SARC-F is a five-question screening tool your GP can administer in under two minutes. It is not diagnostic on its own, but a score of four or above is a reliable prompt to investigate further.
Handgrip strength is measured with a handheld dynamometer. The cut-offs above are EWGSOP2 consensus values; some Australian guidelines use slightly different thresholds depending on the population studied. A single low reading is meaningful, but clinicians usually take the best of three attempts.
Gait speed over four metres is deceptively simple and highly predictive. Slow gait speed correlates with falls risk, hospitalisation, and mortality in older adults, independent of muscle mass alone.
DXA (dual-energy X-ray absorptiometry) is the reference standard for measuring muscle quantity. It is the same machine used for bone density scans, so both can often be assessed in one appointment. Some specialist clinics and hospitals offer this; your GP can refer you.
BIA (bioelectrical impedance analysis) is more accessible and available in many GP clinics and dietitian practices, but results vary by hydration status and the equation used. It is a reasonable screening tool when DXA is not available.
The clinical pathway in Australia typically runs: GP assessment with SARC-F and handgrip test → blood tests (vitamin D, thyroid, inflammatory markers, full blood count) → referral for DXA or allied health assessment → physiotherapist and/or accredited exercise physiologist for a tailored programme.
What is the evidence-based treatment for sarcopenia?
Progressive resistance training is the primary, proven therapy. No medication, supplement, or device replaces it. The evidence is consistent: resistance training and targeted nutrition can slow or partially reverse age-related muscle loss, and the benefits extend to falls reduction, hospitalisation risk, and quality of life.
Exercise prescription
A clinically grounded resistance training programme for sarcopenia typically includes:
Nutrition targets
Older adults with sarcopenia generally need more protein than standard dietary guidelines suggest, because of anabolic resistance. A commonly cited target in clinical reviews is 1.2–1.6 g of protein per kilogram of body weight per day, distributed across meals rather than concentrated in one sitting. Spreading protein intake across three or four meals appears to stimulate muscle protein synthesis more effectively than eating most of it at dinner.
Where whole-food protein intake is insufficient, whey protein supplementation has the strongest evidence base among supplements, partly because of its high leucine content, which is a key trigger for muscle protein synthesis.
Vitamin D deserves a specific mention. Deficiency is common in older Australians, particularly those with limited sun exposure, and low vitamin D is associated with reduced muscle function. A blood test through your GP will confirm your level; supplementation is straightforward if deficient.
Multidisciplinary care
The most effective outcomes come from a team approach:
Evidence comparison: treatment approaches
Timeline for improvement: Measurable strength gains often appear within 6–8 weeks of consistent resistance training. Meaningful functional improvements, such as faster gait speed or easier stair climbing, typically emerge over 3–6 months. Muscle mass recovery is slower and more variable, particularly in those with long-standing sarcopenia.
A safe starter resistance programme for older adults
You do not need a gym membership or complex equipment to begin. The following plan is designed for someone starting from a low base; if you have significant mobility limitations or cardiovascular concerns, discuss it with your GP or physiotherapist first.
Weekly structure: 2–3 resistance sessions, plus daily walking and one balance session.
Session exercises (choose a flat surface, have a chair nearby for support):
Balance session (10–15 minutes, any day): Single-leg stance (hold a bench or wall), tandem walking (heel-to-toe along a line), and gentle side-stepping.
Progression rules:
Safety checkpoints:
Pro Tip: If rising from a chair is currently difficult, start with a higher chair or use a cushion to raise the seat height. As strength improves, lower the seat progressively. This is a safe, measurable way to track functional progress without any equipment.
Can red and near-infrared light therapy support muscle recovery?
Photobiomodulation (PBM), the clinical term for red and near-infrared (NIR) light therapy, is an emerging adjunct in sarcopenia management. It does not replace resistance training or nutrition; the evidence for those is far stronger. What the mechanistic and early clinical data suggest is that PBM can support the conditions that make training more effective.
The biological rationale is straightforward. Red and NIR wavelengths penetrate tissue and are absorbed by cytochrome c oxidase, an enzyme in the mitochondrial respiratory chain. This appears to boost cellular ATP production and reduce oxidative stress, two processes that are compromised in ageing muscle. Separately, PBM has demonstrated anti-inflammatory effects in multiple mechanistic studies, which matters because chronic low-grade inflammation is one of the key drivers of sarcopenia.
Clinical use is increasing, particularly as a post-exercise recovery tool. The rationale: if inflammation and cellular energy deficits slow recovery between training sessions, reducing them may allow older adults to train more consistently and with less downtime. Some practitioners also use it to support muscle repair following injury or hospitalisation.
How it fits into a sarcopenia plan:
Lifespan Dynamics offers both clinical and at-home red and NIR light therapy devices developed in collaboration with clinical researchers, designed to deliver consistent, evidence-aligned parameters for muscle recovery and inflammation support.
Pro Tip: Combine a 10–15 minute PBM session with your post-workout protein meal. Both target the recovery window after resistance training, and pairing them is more practical than treating them as separate routines.
How to reduce your risk of sarcopenia across midlife and later life
Prevention is substantially easier than reversal. The habits that protect muscle mass are the same ones that protect cardiovascular health, bone density, and cognitive function, so the investment compounds across multiple systems.
Core lifetime actions:
For Australians looking for structured community support, Get Active Victoria offers practical movement and strength programmes for older adults. Medicare-funded allied health plans (through a GP Management Plan) can also provide subsidised access to physiotherapy and exercise physiology for those with chronic conditions.
When should you see a GP about muscle loss?
See your GP promptly if you notice:
At the appointment, your GP will likely:
To get the most from the appointment, bring a list of your current medications, note any specific tasks that have become harder and roughly when you first noticed the change, and mention any recent falls or near-misses. Healthdirect Australia has a useful overview of what to expect and how to prepare.
Can sarcopenia be reversed, and what should you realistically expect?
Partial reversal is genuinely possible, particularly when intervention begins before the condition is severe. The word “partial” matters here: the neuromuscular changes that accumulate over decades, including motor neuron loss and imperfect reinnervation, cannot be fully undone. But the functional gains from a well-structured programme can be substantial enough to restore independence and meaningfully reduce falls risk.
Realistic timelines:
Factors that influence how much recovery is achievable:
The encouraging reality is that resistance training and targeted nutrition produce meaningful improvements at virtually any age. Studies in adults in their 80s and 90s show strength and function gains from structured programmes. Starting later is not ideal, but it is never too late to benefit.
An honest perspective on what actually moves the needle
The clinical evidence on sarcopenia is clearer than most people realise, and the gap between what the research supports and what older adults are actually doing is wide. Resistance training and protein intake are not optional extras for ageing well; they are the primary intervention, and the data behind them is as strong as the evidence for many medications prescribed for age-related conditions.
What tends to get underestimated is how quickly muscle responds to the right stimulus, even in older adults. The early strength gains from resistance training, driven largely by neural adaptation, can appear within weeks and feel genuinely motivating. That momentum matters, because adherence is the variable that determines long-term outcomes more than any specific programme design.
Where adjunct therapies like photobiomodulation fit is as a recovery support, not a shortcut. The mitochondrial and anti-inflammatory mechanisms are real and increasingly well-documented. Used alongside a consistent resistance programme and adequate protein, they can help older adults recover between sessions more effectively, which means training more consistently. That is the mechanism through which they contribute, not by replacing the hard work of exercise.
The practical advice: start with your GP, get a baseline assessment, and build the exercise and nutrition habits first. If you want to explore light therapy as a recovery adjunct, discuss it with your clinician and look for devices with peer-reviewed parameters. Lifespan Dynamics devices are developed with clinical researchers and designed for exactly this kind of supervised, evidence-aligned use.
Lifespan Dynamics light therapy devices: a clinician-aligned adjunct for muscle recovery
If you are building a sarcopenia management plan around resistance training and nutrition, and you want to support your recovery between sessions, Lifespan Dynamics offers red and near-infrared light therapy devices designed for both clinical and home use.
Developed in collaboration with internationally recognised researchers, including Professor Sungkyoo Lim, these devices are built to deliver consistent, peer-reviewed wavelength parameters for muscle recovery and inflammation reduction. They are used by physiotherapists, exercise physiologists, and individuals managing chronic conditions at home. The positioning is clear: these are adjuncts to exercise and nutrition, not replacements. Used as part of a clinician-supervised plan, they support the cellular recovery processes that make consistent training possible.
To explore the range of at-home and clinical devices, or to discuss which option suits your situation, visit the Lifespan Dynamics website. Always discuss new therapies with your GP or allied health provider before starting.
Sources
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Can you reverse muscle degeneration?
Partial reversal is possible, particularly with early intervention. Progressive resistance training and adequate protein intake can restore meaningful strength and function, though full recovery of lost muscle mass, especially after years of decline, is unlikely. Starting earlier produces better outcomes.
Can a 70-year-old regain muscle mass?
Yes. Studies in adults in their 70s, 80s, and beyond consistently show strength and functional gains from structured resistance training. Mass recovery is slower than strength recovery, but measurable improvements in both are achievable with consistent effort and sufficient protein intake.
What are the main symptoms of sarcopenia?
The four most common functional signs are difficulty rising from a chair without using your arms, a noticeably slower walking pace, reduced grip strength (trouble opening jars or carrying bags), and an increased tendency to trip or fall. Fatigue with tasks that previously felt easy is also a reliable early indicator.
How do you know if you have muscle degeneration?
The SARC-F questionnaire is a simple five-question self-screen; a score of four or more suggests sarcopenia is likely. Objective confirmation comes from a handgrip strength test, a four-metre gait speed assessment, and muscle mass measurement via DXA scan or bioelectrical impedance, all available through a GP referral in Australia.
Recommended